Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 16.33 3.16% 0.50
ACAD closed up 3.16 percent on Tuesday, June 19, 2018, on 1.92 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ACAD trend table...

Date Alert Name Type % Chg
Jun 19 180 Bearish Setup Bearish Swing Setup 0.00%
Jun 19 Lower Bollinger Band Walk Weakness 0.00%
Jun 19 Gapped Up Strength 0.00%
Jun 19 Up 3 Days in a Row Strength 0.00%
Jun 19 Oversold Stochastic Weakness 0.00%
Jun 18 Lower Bollinger Band Walk Weakness 3.16%
Jun 18 Lower Bollinger Band Touch Weakness 3.16%
Jun 18 Oversold Stochastic Weakness 3.16%
Jun 15 New Downtrend Bearish 3.81%
Jun 15 Lower Bollinger Band Walk Weakness 3.81%

Older signals for ACAD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimer's disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Is ACAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.2
52 Week Low 14.51
Average Volume 3,097,327
200-Day Moving Average 27.2762
50-Day Moving Average 17.7732
20-Day Moving Average 17.2085
10-Day Moving Average 16.758
Average True Range 0.9376
ADX 25.31
+DI 23.29
-DI 27.47
Chandelier Exit (Long, 3 ATRs ) 15.7472
Chandelier Exit (Short, 3 ATRs ) 17.7128
Upper Bollinger Band 18.8816
Lower Bollinger Band 15.5354
Percent B (%b) 0.24
BandWidth 19.445042
MACD Line -0.6058
MACD Signal Line -0.4775
MACD Histogram -0.1283
Fundamentals Value
Market Cap 2 Billion
Num Shares 122 Million
EPS -2.53
Price-to-Earnings (P/E) Ratio -6.45
Price-to-Sales 67.33
Price-to-Book 10.21
PEG Ratio -0.41
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.40
Resistance 3 (R3) 18.55 18.01 18.06
Resistance 2 (R2) 18.01 17.48 17.94 17.94
Resistance 1 (R1) 17.17 17.16 17.59 17.02 17.82
Pivot Point 16.63 16.63 16.84 16.56 16.63
Support 1 (S1) 15.79 16.10 16.21 15.64 14.84
Support 2 (S2) 15.25 15.78 15.18 14.72
Support 3 (S3) 14.41 15.25 14.61
Support 4 (S4) 14.26